What is the ticker symbol for Replimune?

Replimune trades under the ticker REPL on NASDAQ.

What sector does Replimune operate in?

Replimune is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze REPL in a portfolio?

PortView shows REPL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Replimune (REPL) Stock Analysis

NASDAQHealthcareBiotechnology

$15.57-0.66%

1-year price historyRange $1.70 – $15.88

52-week range$15.57

$1.50$16.33

What Replimune does

Replimune Group, Inc. is a biotechnology enterprise dedicated to pioneering oncolytic immuno-gene therapies aimed at treating various cancers. The company leverages its proprietary Immunotherapy platform to engineer and advance novel therapeutic candidates designed to activate the body's immune system against malignant cells. Its leading experimental drug, RP1, is a selectively replicating variant of the herpes simplex virus 1. This candidate is presently in Phase I/II clinical trials for a range of solid tumors and has also progressed to Phase II trials specifically for patients with cutaneous squamous cell carcinoma. Replimune is additionally developing RP2, an anti-CTLA-4 antibody-like protein, which is undergoing Phase I clinical assessment. Its purpose is to counteract the immune system's suppression often mediated by CTLA-4. Furthermore, RP3, also in Phase I clinical trials, is engineered to express immune-activating proteins that stimulate T cells. Established in 2015, Replimune Group, Inc. maintains its corporate headquarters in Woburn, Massachusetts.

Key metrics

Market cap

$1.31B

P/E (TTM)

-4.94

EPS (TTM)

$-3.15

Beta

0.90

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$12.00

200-day avg

$8.50

52-week high

$16.33

52-week low

$1.50

CEO

Sushil Patel

ETFs linked to REPL

Broad-market and Healthcare sector ETFs an investor holding Replimune is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how REPL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze REPL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Replimune?: Replimune trades under the ticker REPL on NASDAQ.
Which exchange is REPL listed on?: REPL is listed on NASDAQ.
What sector does Replimune operate in?: Replimune is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze REPL in a portfolio?: PortView shows REPL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.